NCT07746180
- Conditions
- ANCA-Associated Glomerulonephritis (AAGN), ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, +9 more
- Locations
-
- Chinese PLA General Hospital Beijing, China
Clinical trial condition
ANCA-Associated Vasculitis (AAV)
Explore clinical trials studying ANCA-Associated Vasculitis (AAV). Study availability and eligibility vary by location and protocol.
8 public trials
5 recruiting studies
ANCA-Associated Vasculitis (AAV) trial results
Recruiting
FT839 in Autoimmune Diseases
NCT07800871
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +26 more
- Locations
-
- Providence Medical Foundation Fullerton, California, United States
NCT07089121
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
- Locations
-
- H01- Children's National Hospital Washington D.C., District of Columbia, United States
- H03- Washington University School of Medicine St Louis, Missouri, United States
- Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States
NCT07526350
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arthritis, +32 more
- Locations
-
- Shanghai ChangZheng Hospital Shanghai, Shanghai Municipality, China
Recruiting
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
NCT06941129
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +21 more
- Locations
-
- Institute of Hematology & Blood Diseases Hospital Tianjin, China
Not yet recruiting
Avacopan Added to Standard-of-care Therapy in ANCA-associated Vasculitis With Severe Kidney Involvement
NCT07373262
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +8 more
- Locations
-
- Amiens Hospital Amiens, France
- Angers Hospital Angers, France
- Besançon Hospital Besançon, France
- Bordeaux Hospital Bordeaux, France
Enrolling by invitation
A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease
NCT06375993
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +33 more
- Locations
-
- Adicet Clinical Trials Redwood City, California, United States
- Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
NCT02507024
- Conditions
- ANCA-Associated Vasculitis (AAV), Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +28 more
- Locations
-
- University of South Florida Tampa, Florida, United States
- University of Pennsylvania Philadelphia, Pennsylvania, United States